A gene signature for a long-term survivor of an atypical teratoid/rhabdoid tumor

Cancer Genetics

Volumn 207, Issue 9, 2014, Pages 420-424

  Sredni, Simone T ^a,b,c   Huang, Chiang Ching ^d   Pundy, Tatiana ^a   Patel, Kashyap ^a   Halpern, Abby L ^a   Grupenmacher, Alex T ^a   Chou, Pauline M ^a,b   Bonaldo, Maria de Fátima ^b,c   Tomita, Tadanori ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Lurie Children's Research Center   (United States)

^d UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

AT RT; Gene expression; Long term survivor; Rhabdoid

Indexed keywords

CARBOPLATIN; CISPLATIN; COMPLEMENTARY DNA; CONNEXIN 26; CYCLOPHOSPHAMIDE; ETOPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; ATYPICAL TERATOID; BRAIN SURGERY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVOR; CASE REPORT; CAUSE OF DEATH; CHILD; CLUSTER ANALYSIS; DCN GENE; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; DNA MICROARRAY; FOXN2 GENE; GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENETIC ASSOCIATION; GJB2 GENE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LONG TERM SURVIVAL; MALE; MULTIPLE CYCLE TREATMENT; NEUROECTODERM TUMOR; PRESCHOOL CHILD; RAB40B GENE; RHABDOID TUMOR; SMARCB1 GENE; SPINAL CORD METASTASIS; TERATOMA; TREATMENT OUTCOME; BRAIN NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; MORTALITY; PATHOLOGY; RADIOGRAPHY; SURVIVOR; TUMOR RECURRENCE;

ADOLESCENT; BRAIN NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; RHABDOID TUMOR; SURVIVORS; TERATOMA;

EID: 84920278637     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2014.05.009     Document Type: Article

References (23)

1. Zhuge Y., Cheung M.C., Yang R., et al. Pediatric non-Wilms renaltumors: subtypes, survival, and prognostic indicators. JSurg Res 2010, 163:257-263.
2. Sultan I., Qaddoumi I., Rodriguez-Galindo C., et al. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer 2010, 54:35-40.
3. Tomlinson G.E., Breslow N.E., Dome J., et al. Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. JClin Oncol 2005, 23:7641-7645.
4. Dufour C., Beaugrand A., Le Deley M.C., et al. Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 2012, 118:3812-3821.
5. Strother D. Atypical teratoid rhabdoid tumors of childhood: diagnosis, treatment and challenges. Expert Rev Anticancer Ther 2005, 5:907-915.
6. Chi S.N., Zimmerman M.A., Yao X., et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. JClin Oncol 2009, 27:385-389.
7. Fidani P., De Ioris M.A., Serra A., et al. Amultimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid/rhabdoid tumours: a single institution experience. JNeurooncol 2009, 92:177-183.
8. Hilden J.M., Meerbaum S., Burger P., et al. Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. JClin Oncol 2004, 22:2877-2884.
9. Tekautz T.M., Fuller C.E., Blaney S., et al. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. JClin Oncol 2005, 23:1491-1499.
10. Gardner S.L., Asgharzadeh S., Green A., et al. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 2008, 51:235-240.
11. Ammerlaan A.C., Ararou A., Houben M.P., et al. Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndrome. Br J Cancer 2008, 98:474-479.
12. Takahashi-Fujigasaki J., Matumoto M., Kan I., et al. Atypical teratoid/rhabdoid tumor with 26-year overall survival: case report. JNeurosurg Pediatr 2012, 9:400-405.
13. Hirth A., Pedersen P.H., Wester K., et al. Cerebral atypical teratoid/rhabdoid tumor of infancy: long-term survival after multimodal treatment, also including triple intrathecal chemotherapy and gamma knife radiosurgery-case report. Pediatr Hematol Oncol 2003, 20:327-332.
14. Sasani M., Oktenoglu T., Ozer A.F., et al. Giant supratentorial atypical teratoid/rhabdoid tumor presentation: a case of a five-year-old child with favorable outcome and review of the literature. Pediatr Neurosurg 2007, 43:149-154.
15. Donovan D.J., Smith A.B., Petermann G.W. Atypical teratoid/rhabdoid tumor of the velum interpositum presenting as a spontaneous intraventricular hemorrhage in an infant: case report with long-term survival. Pediatr Neurosurg 2006, 42:187-192.
16. Takahashi K., Nishihara H., Katoh M., et al. Case of atypical teratoid/rhabdoid tumor in an adult, with long survival. Brain Tumor Pathol 2011, 28:71-76.
17. Olson T.A., Bayar E., Kosnik E., et al. Successful treatment of disseminated central nervous system malignant rhabdoid tumor. JPediatr Hematol Oncol 1995, 17:71-75.
18. Bouvier C., De Paula A.M., Fernandez C., et al. Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy. Childs Nerv Syst 2008, 24:143-147.
19. Zimmerman M.A., Goumnerova L.C., Proctor M., et al. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor. JNeurooncol 2005, 72:77-84.
20. Pomeroy S.L., Tamayo P., Gaasenbeek M., et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436-442.
21. Birks D.K., Donson A.M., Patel P.R., et al. High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival. Neuro Oncol 2011, 13:1296-1307.
22. Du S., Wang S., Wu Q., et al. Decorin inhibits angiogenic potential of choroid-retinal endothelial cells by downregulating hypoxia-induced Met, Rac1, HIF-1alpha and VEGF expression in cocultured retinal pigment epithelial cells. Exp Eye Res 2013, 116:151-160.
23. Ableser M.J., Penuela S., Lee J., et al. Connexin43 reduces melanoma growth within a keratinocyte microenvironment and during tumorigenesis invivo. JBiol Chem 2014, 289:1592-1603.